1. Müller-Eberhard HJ. The human complement protein C3: its unusual functional and structural versatility in host defense and inflammation. In: Weigle WO editor, Advances in Immunopathology. Miami: Symp. Specialists Inc; 1981: 141–60.
2. Seijelid R, Bögwald J, Lundwall A. Glycan stimulation of macrophages in vitro. Exp Cell Res, 1981; 131: 121–9.
3. Hadding U, Dierich M, Konig W, Limbert M, Schorlemmer HU, Bitter-Suermann D. Ability of the T cell-replacing polyanion dextran sulfate to trigger the alternate pathway of complement activation. Europ J Immunol, 1973; 3, 527–9.
4. Ray TL, Hanson A, Ray LF, Wuepper KD. Purification of a mannan from Candida albicans which activates serum complement. J Invest Dermatol 1979; 73: 269–74.
5. Cooper PD. Complement and Cancer: activation of the alternative pathway as a theoretical base for immunotherapy. In: Ray PK, editor. Advances in Immunology and Cancer Therapy Vol. 1. New York: Springer-Verlag; 1985; 125–66.